Preclinical and clinical evidence for stem cell therapies as treatment for diabetic wounds

Drug Discovery Today

Volumn 20, Issue 6, 2015, Pages 703-717

  Heublein, Hannes ^a   Bader, Augustinus ^a   Giri, Shibashish ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; NEUTROPHIL COLLAGENASE; PLACENTAL GROWTH FACTOR; PLACENTAL GROWTH FACTOR 2; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT GROWTH FACTOR; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANGIOGENESIS; BONE MARROW DERIVED MESENCHYMAL STEM CELL; DIABETES MELLITUS; DIABETIC FOOT; ENDOTHELIAL PROGENITOR CELL; HUMAN; LEG AMPUTATION; LOW DRUG DOSE; MONONUCLEAR STEM CELL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PLACENTA; REVIEW; STEM CELL TRANSPLANTATION; UMBILICAL CORD BLOOD; WOUND; WOUND HEALING; AMPUTATION; ANIMAL; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; GENETICS; LIMB SALVAGE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; PHYSIOLOGY; SIGNAL TRANSDUCTION; STEM CELL; TREATMENT OUTCOME;

AMPUTATION; ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; DIABETIC FOOT; HUMANS; LIMB SALVAGE; PHENOTYPE; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION; STEM CELLS; TREATMENT OUTCOME; WOUND HEALING;

EID: 84934968330     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2015.01.005     Document Type: Review

References (145)

1. International Diabetes Federation (2013) Diabetes Atlas 2013. International Diabetes Federation
2. Reiber, G. E. et al. (1999) Causal pathways for incident lower-extremity ulcer in patients with diabetes from two setting. Diabetes Care 22, 157-162
3. Reiber, G. E. et al. (1995) Lower Extremity Foot Ulcers and AmputationsinDiabetes. In Diabetes in America (Maureen, I. H., Catherine, C. C., Michael, P. S., Edward, J. B., Gayle, E. R. and Peter H. B., eds), pp. 409-428, US Government Printing Office
4. Deutsche Diabetes Gesellschaft, and AG Diabetischer Fuß, (2012) Die meisten Amputationen in Deutschland sind Folge von Diabetes - und ließen sich verhindern. Deutsche Diabetes Gesellschaft
5. Margolis, D. J. et al. (2013) Lack of effectiveness of hyperbaric oxygen therapy for the treatment of diabetic foot ulcer and the prevention of amputation: a cohort study. Diabetes Care 36, 1961-1966
6. Hocking, A. M. and Gibran, N. S. (2010) Mesenchymal stem cells: paracrine signaling and differentiation during cutaneous wound repair. Exp. Cell Res. 316, 2213-2219
7. Lee, M. J. et al. (2011) Enhancement of wound healing by secretory factors of endothelial precursor cells derived from human embryonic stem cells. Cytotherapy 13, 165-178
8. Maruyama, K. et al. (2007) Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic would healing. Am. J. Pathol. 170, 1178-1191
9. Galkowska, H. et al. (2006) Chemokines, cytokines, and growth factors in keratinocytes and dermal endothelial cells in the margin of chronic diabetic foot ulcers. Wound Repair Regen. 14, 558-565
10. Goren, I. et al. (2006) Severely impaired insulin signaling in chronic wounds of diabetic ob/ob mice: a potential role of tumor necrosis factor-alpha. Am. J. Pathol. 168, 765-777
11. Falanga, V. (2005) Wound healing and its impairment in the diabetic foot. Lancet 366, 1736-1743
12. Galiano, R. D. et al. (2004) Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells. Am. J. Pathol. 164, 1935-1947
13. Gibran, N. S. et al. (2002) Diminished neuropeptide levels contribute to the impaired cutaneous healing response associated with diabetes mellitus. J. Surg. Res. 108, 122-128
14. Lobmann, R. et al. (2002) Expression of matrix metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients. Diabetologia 45, 1011-1016
15. Stojadinovic, O. et al. (2005) Molecular pathogenesis of chronic wounds: the role of beta-catenin and c-myc in the inhibition of epithelialization and wound healing. Am. J. Pathol. 167, 59-69
16. Brem, H. et al. (2007) Molecular markers in patients with chronic woundsto guide surgical debridement. Mol. Med. 13, 30-39
17. Han, Y. P. et al. (2001) TNF-α stimulates activation of pro-MMP2 in human skin through NF-κB mediated induction of MT1-MMP. J. Cell Sci. 114, 131-139
18. Hübner, G. et al. (1996) Differential regulation of pro-inflammatory cytokines during wound healing in normal and glucocorticoid-treated mice. Cytokine 8, 548-556
19. Ponugoti, B. et al. (2012) Role of forkhead transcription factors in diabetes-induced oxidative stress. Exp. Diabetes Res. 2012, 939751
20. Siqueira, M. F. et al. (2010) Impaired wound healingin mouse modelsof diabetes is mediated by TNF-a dysregulation and associated with enhanced activation of forkhead box O1 (FOXO1). Diabetologia 53, 378-388
21. Petrache, I. et al. (2000) Heme oxygenase-1 inhibits TNF-a-induced apoptosis in cultured fibroblasts. Am. J. Physiol. 278, L312-L319
22. Ruckert, R. et al. (2000) High dose proinflammatory cytokines induce apoptosis of hair bulb keratinocytes in vivo. Br. J. Dermatol. 143, 1036-1039
23. Corredor, J. et al. (2003) Tumor necrosis factor regulates intestinal epithelial cell migration by receptor-dependent mechanisms. Am. J. Physiol. 284, C953-C961
24. Potente, M. et al. (2005) Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularization. J. Clin. Invest. 115, 2382-2392
25. Gallagher, K. A. et al. (2007) Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1a. J. Clin. Invest. 117, 1249-1259
26. Potter, C. F. et al. (1999) Effects of hyperoxia on nitric oxide synthase expression, nitric oxide activity, and lung injury in rat pups. Pediatr. Res. 45, 8-13
27. Jude, E. B. et al. (2002) Transforming growth factor-beta 1, 2, 3 and receptor type I and II in diabetic foot ulcers. Diabet. Med. 19, 440-447
28. Tsunawaki, S. et al. (1988) Deactivation of macrophages by transforming growth factor-beta. Nature 334, 260-262
29. Gillitzer, R. and Goebeler, M. (2001) Chemokines in cutaneous wound healing. J. Leukoc. Biol. 69, 513-521
30. Dickinson, P. J. et al. (2002) Neurovascular disease, antioxidants and glycation in diabetes. Diabetes Metab. Res. Rev. 18, 260-272
31. Chen, W. Y. and Rogers, A. A. (2007) Recent insights into the causes of chronic leg ulceration in venous diseases and implications on other types of chronic wounds. Wound Repair Regen. 15, 434-449
32. Teixeira, A. S. and Anrade, S. P. (1999) Glucose-induced inhibition of angiogenesis in the rat sponge granulomaisprevented by aminoguanidine. Life Sci. 64, 655-662
33. Hickey, M. M. and Simon, M. C. (2006) Regulation of angiogenesis by hypoxia and hypoxia-inducible factors. Curr. Top. Dev. Biol. 76, 217-257
34. Fong, G. H. (2008) Mechanisms of adaptive angiogenesis to tissue hypoxia. Angiogenesis 11, 121-140
35. Catrina, S. B. et al. (2004) Hyperglycemia regulates hypoxia-inducible factor-1 alpha protein stability and function. Diabetes 53, 3226-3232
36. Grotendorst, G. R. et al. (1989) EGF and TGF-alpha are potent chemoattractants for endothelial cells and EGF-like peptides are present at sites of tissue regeneration. J. Cell Physiol. 139, 617-623
37. Pierce, G. F. et al. (1992) Platelet-derived growth factor (BB homodimer), transforming growth factor-beta 1, and basic fibroblast growth factor in dermal wound healing. Neovessel and matrix formation and cessation of repair. Am. J. Pathol. 140, 1375-1388
38. Strieter, R. M. et al. (1995) The functional role of the ELR motif inCXC chemokinemediated angiogenesis. J. Biol. Chem. 270, 27348-27357
39. Castronuovo, J. J., Jr et al. (1998) Effects of chronic wound fluid on the structure and biological activity of becaplermin (rhPDGF-BB) and becaplermin gel. Am. J. Surg. 176 61S-67S
40. Blakytny, R. et al. (2000) Lack of insulin-like growth factor 1 (IGF-1) in the basal keratinocyte layer of diabetic skin and diabetic foot ulcers. J. Pathol. 190, 589-594
41. Kawamoto, K. and Matsuda, H. (2004) Nerve growth factor and wound healing. Prog. Brain Res. 146, 369-384
42. Galkowska, H. et al. (2006) Neurogenic factors in the impaired healing of diabetic foot ulcers. J. Surg. Res. 134, 252-258
43. Guvakova, M. A. (2007) Insulin-like growth factors control cell migration in health and disease. Int. J. Biochem. Cell Biol. 39, 890-909
44. Jude, E. B. et al. (2001) Role of neuropathy and plasma nitric oxide in recurrent neuropathic and neuroischemic diabetic foot ulcers. Wound Repair Regen. 9, 353-359
45. Jude, E. B. et al. (1999) The role of nitric oxide synthase isoforms and arginase in the pathogenesis of diabetic foot ulcers: possible modulatory effects by transforming growth factor beta 1. Diabetologia 42, 748-757
46. Trengove, N. J. et al. (1999) Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Repair Regen. 7, 442-452
47. Galkowska, H. et al. (2005) Low recruitment of immune cells with increased expression of endothelial adhesion molecules in margins of the chronic diabetic foot ulcers. Wound Repair Regen. 13, 248-254
48. Rechardt, O. et al. (2000) Stromelysin-2isupregulatedduring normal wound repair and is induced by cytokines. J. Invest. Dermatol. 115, 778-787
49. Armstrong, D. G. and Jude, E. B. (2002) The role of matrix metalloproteinases in wound healing. J. Am. Pediatr. Med. Assoc. 92, 12-18
50. Lobmann, R. et al. (2002) Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients. Diabetologia 45, 1011-1016
51. Pirilä, E. et al. (2007) Collagenase-2 (MMP-8) and matrilysin-2 (MMP-26) expression in human wounds of different etiologies. Wound Repair Regen. 15, 47-57
52. Hehenberger, K. et al. (1998) Fibroblasts derived from human chronic diabetic wounds have a decreased proliferation rate, which is recovered by the addition of heparin. J. Dermatol. Sci. 16, 144-151
53. Loot, M. A. et al. (2002) Fibroblasts derived from chronic diabetic ulcers differ in their response to stimulation with EGF, IGF-1, bFGF and PDGF-AB compared to controls. Eur. J. Cell Biol. 81, 153-160
54. Edwards, D. R. et al. (1987) Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J. 6, 1899-1904
55. Yamamoto, T. et al. (2000) Monocyte chemoattractant protein-1 enhances gene expression and synthesisofmatrix metalloproteinase-1inhumanfibroblastsbyan autocrine IL-1 alpha loop. J. Immunol. 164, 6174-6179
56. Moore, K. W. et al. (2001) Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19, 683-765
57. Philips, N. et al. (2004) TGF beta-like regulation of matrix metalloproteinases by anti-transforming growth factor-beta, and anti-transforming growth factor-beta 1 antibodies in dermal fibroblasts: implications for wound healing. Wound Repair Regen. 12, 53-59
58. Mimura, Y. et al. (2006) Epidermal growth factor affects the synthesis and degradation of type I collagen in cultured human dermal fibroblasts. Matrix Biol. 25, 202-212
59. Barrientos, S. et al. (2008) Growth factors and cytokines in wound healing. Wound Repair Regen. 16, 585-601
60. Rennekampff, H. O. et al. (2000) Bioactive interleukin-8isexpressedinwounds and enhances wound healing. J. Surg. Res. 93, 41-54
61. Yano, S. et al. (2003) Interleukin 15 induces the signals of epidermal proliferation through ERK and PI 3-kinase in a human epidermal keratinocyte cell line, HaCaT. Biochem. Biophys. Res. Commun. 301, 841-847
62. Botchkarev, V. A. et al. (2006) Neurotrophins in skin biology and pathology. J. Invest. Dermatol. 126, 1719-1727
63. Roosterman, D. et al. (2006) Neuronal control of skin function: the skin as a neuroimmunoendocrine organ. Physiol. Rev. 86, 1309-1379
64. Usui, M. L. et al. (2008) Keratinocyte migration, proliferation, and differentiation in chronic ulcers from patients with diabetes and normal wounds. J. Histochem. Cytochem. 56, 687-696
65. Lindsay, R. M. et al. (1989) Neuropeptide expression in cultures of adult sensory neurons: modulation of substance P and calcitonin gene-related peptide levels by nerve growth factor. Neuroscience 33, 53-65
66. Yasuda, H. et al. (2003) Diabetic neuropathy and nerve regeneration. Prog. Neurobiol. 69, 229-285
67. Antezana, M. et al. (2002) Neutral endopeptidase activity is increased in the skin of subjects with diabetic ulcers. J. Invest. Dermatol. 119, 1400-1404
68. Muangman, P. et al. (2003) Fatty acids and glucose increase neutral endopeptidase activity in human microvascular endothelial cells. Shock 19, 508-512
69. Culcasi, M. et al. (1994) Glutamate receptors induce a burst of superoxide via activation of nitric oxidase synthase in arginine-depleted neurons. J. Biol. Chem. 269, 12589-12593
70. Beckman, J. S. et al. (1990) Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. U. S. A. 87, 1620-1624
71. Mudge, B. P. et al. (2002) Roleofglutathione redox dysfunctionindiabetic wounds. Wound Repair Regen. 10, 52-58
72. Maritim, A. C. et al. (2003) Diabetes, oxidative stress, and antioxidants: a review. J. Biochem. Mol. Toxicol. 17, 24-38
73. Monboisse, J. C. and Borel, J. P. (1992) Oxidative damage to collagen. EXS 62, 323-327
74. Kennet, E. C. and Davies, M. J. (2007) Degradation of matrix glycosaminoglycans by peroxynitrite/peroxynitrous acid: evidence for a hydroxyl-radical-like mechanism. Free Radic. Biol. Med. 42, 1278-1289
75. Runager, K. et al. (2013) Targeting O-glycosyltransferase (OGT) to promote healing of diabetic skin wounds. J. Biol. Chem. 289, 5462-5466
76. Mirza, R. E. et al. (2013) Blocking interleukin-1β induces a healing-associated wound macrophage phenotype and improves healing in type 2 diabetes. Diabetes 62, 2579-2587
77. Yu, H. et al. (2014) Sphingosine kinase 1 improves cutaneous wound healing in diabetic rats. Injury 45, 1054-1058
78. Arya, A. K. et al. (2014) Promising role of ANGPTL4 geneindiabetic wound healing. Int. J. Low Extrem. Wounds 13, 58-63
79. Swagada, N. et al. (2014) Endothelial PGC-1α mediates vascular dysfunction in diabetes. Cell Metab. 19, 246-258
80. Squadrito, F. et al. (2014) The effect of PDRN, an adenosine receptor A2A agonist, on the healing of chronic diabetic foot ulcers: results of a clinical trial. J. Clin. Endocrinol. Metab. 99, E746-E753
81. Shen, Y. et al. (2012) Plasminogen is a key pro-inflammatory regulator that accelerates the healing of acute and diabetic wounds. Blood 119, 5879-5887
82. Bitto, A. et al. (2014) Inhibition of inflammasome activation improves the impaired pattern of healing in genetically diabetic mice. Br. J. Pharmacol. 71, 2300-2307
83. Saghizadeh, M. et al. (2013) Enhanced wound healing, kinase and stem cell marker expression in diabetic organ-cultured human corneas upon MMP-10 and cathepsin F gene silencing. Invest. Ophthalmol. Vis. Sci. 54, 8172-8180
84. Botusan, I. R. et al. (2008) Stabilization of HIF-1alpha is critical to improve wound healing in diabetic mice. Proc. Natl. Acad. Sci. U. S. A. 105, 19426-19431
85. Bader, A. et al. (2011) Interactive role of trauma cytokines and erythropoietin and their therapeutic potential for acute and chronic wounds. Rejuvenation Res. 14, 57-66
86. Martino, M. M. et al. (2014) Growth factors engineered for super-affinity to the extracellular matrix enhance tissue healing. Science 343, 885
87. Gooyit, M. et al. (2014) A chemical biological strategy to facilitate diabetic wound healing. ACS Chem. Biol. 9, 105-110
88. Rafehi, H. et al. (2011) Genetic and epigenetic events in diabetic wound healing. Int. Wound J. 8, 12-21
89. Pirola, L. (2010) Epigenetic phenomena linked to diabetic complications. Nat. Rev. Endocrinol. 6, 665-675
90. Gnecchi, M. and Melo, L. G. (2009) Bone marrow-derived mesenchymal stem cells: isolation, expansion, characterization, viral transduction, and production of conditioned medium. Methods Mol. Biol. 482, 281-294
91. Conget, P. A. and Minguel, J. J. (1999) Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells. J. Cell Physiol. 181, 67-73
92. Galmiche, M. C. et al. (1993) Stromal cells from human long-term marrow cultures are mesenchymal cells that differentiate following a vascular smooth muscle differentiation pathway. Blood 82, 66-76
93. Haynesworth, S. E. et al. (1992) Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. Bone 13, 69-80
94. Martinez, C. et al. (2007) Human bone marrow mesenchymal stromal cells express the neural ganglioside GD2: a novel surface marker for identification of MSCs. Blood 109, 4245-4248
95. Sachetti, B. et al. (2007) Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 131, 324-336
96. Shi, S. et al. (2003) Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp. J. Bone Miner. Res. 18, 696-704
97. Shi, S. et al. (2002) Bone formationbyhuman postnatal bone marrow stromal stem cells in enhanced by telomerase expression. Nat. Biotechnol. 20, 587-591
98. Sordi, V. et al. (2005) Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Blood 106, 419-427
99. Gronthos, S. et al. (2003) Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. J. Cell Sci. 116, 1827-1835
100. Simmons, P. J. and Torok-Storb, B. (1991) Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood 78, 55-62
101. Vojtassak, J. et al. (2006) Autologous biograft and mesenchymal stem cells in treatment of the diabetic foot. Neuro Endocrinol. Lett. 27, 134-137
102. Javazon, E. H. et al. (2007) Enhanced epithelial gap closure and increased angiogenesis in wounds of diabetic mice treated with adult murine bone marrow stromal progenitor cells. Wound Repair Regen. 15, 350-359
103. Wu, Y. et al. (2007) Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells 25, 2648-2659
104. Lu, D. et al. (2008) Autologous transplantationofbone marrow mesenchymal stem cells on diabetic patients with lower limb ischemia. J. Med. Coll. PLA 23, 106-115
105. Wan, J. et al. (2013) Transplantation of bone marrow-derived mesenchymal stem cells promotes delayed wound healingin diabetic rats. J. Diabetes Res. 2013, 647107
106. Falanga, V. et al. (2007) Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds. Tissue Eng. 13, 1299-1312
107. Ravari, H. et al. (2011) Treatment of non-healing wounds with autologous bone marrow cells, platelets, fibrin glue and collagen matrix. Cytotherapy 13, 705-711
108. Mansilla, E. et al. (2010) Outstanding survival and regeneration process by the use of intelligent acellular dermal matrices and mesenchymal stem cells in a burn pig model. Transplant Proc. 42, 4275-4278
109. McFarlin, K. et al. (2006) Bone marrow-derived mesenchymal stromal cells accelerate wound healing in the rat. Wound Repair Regen. 14, 471-478
110. Stoff, A. et al. (2009) Promotion of incisional wound repair by human mesenchymal stem cell transplantation. Exp. Dermatol. 18, 362-369
111. Chen, L. et al. (2009) Analysis of allogenicity of mesenchymal stem cells in engraftment and wound healing in mice. PLoS ONE 4, e7119
112. Amin, A. H. et al. (2010) Modified multipotent stromal cells with epidermal growth factor restore vasculogenesis and blood flow in ischemic hind-limb of type II diabetic mice. Lab. Invest. 90, 985-996
113. Sasaki, M. et al. (2008) Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. J. Immunol. 180, 2581-2587
114. Chen, L. et al. (2008) Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS ONE 3, e1886
115. Kuo, Y. R. et al. (2011) Bone marrow-derived mesenchymal stem cells enhanced diabetic wound healing through recruitment of tissue regeneration in a rat model of streptozotocin-induced diabetes. Plast. Reconstr. Surg. 128, 872-880
116. Kim, C. H. et al. (2011) Mesenchymal stem cells improve wound healinginvivo via early activation of matrix metalloproteinase-9 and vascular endothelial growth factor. J. Korean Med. Sci. 26, 726-733
117. Martin, P. (1997) Wound healing - aiming for perfect skin regeneration. Science 276, 75-81
118. Singer, A. J. and Clark, R. A. (1999) Cutaneous wound healing. N. Engl. J. Med. 341, 738-746
119. Lu, D. et al. (2011) Comparisonofbone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: a double-blind, randomized, controlled trial. Diabetes Res. Clin. Pract. 92, 26-36
120. Humpert, P. M. et al. (2005) Locallyapplied mononuclear bone marrow cells restore angiogenesis and promote wound healing in a type 2 diabetic patient. Exp. Clin. Endocrinol. Diabetes 113, 538-540
121. Bartsch, T. et al. (2005) Rapid healing of a therapy-refractory diabetic foot after transplantation of autologous bone marrow stem cells. Med. Klin. 100, 676-680
122. Kohlmann-Trigoboff, D. et al. (2006) Stem cell use in a patient with an ischemic foot ulcer: a case study. J. Vasc. Nurs. 24, 56-61
123. Kirana, S. et al. (2007) Wound therapy with autologous bone marrow stem cells in diabetic patients with ischaemia-induced tissue ulcers affecting the lower limbs. Int. J. Clin. Pract. 61, 690-692
124. Subrammaniyan, R. et al. (2011) Application of autologous bone marrow mononuclear cells in six patients with advanced chronic critical limb ischemia as a result of a diabetes: our experience. Cytotherapy 13, 993-999
125. Kirana, S. et al. (2012) Autologous stem cell therapy in the treatment of limb ischaemia induced chronic tissue ulcers of diabetic foot patients. Int. J. Clin. Pract. 66, 384-393
126. Castilla, D. M. et al. (2012) A novel autologous cell based therapy to promote diabetic wound healing. Ann. Surg. 256, 560-572
127. Dubsky, M. et al. (2013) Both autologous bone marrow mononuclear cell and peripheral blood progenitor cell therapies similarly improve ischaemia in patients with diabetic foot in comparison with control treatment. Diabetes Metab. Res. Rev. 29, 369-376
128. Ozturk, A. et al. (2012) Therapeutical potential of autologous peripheral blood mononuclear cell transplantation in patients with type 2 diabetic critical limb ischemia. J. Diabetes Complications 26, 29-33
129. Kawamura, A. et al. (2005) Prevention of limb amputation in patients with limbs ulcers by autologous peripheral blood mononuclear cell implantation. Ther. Apher. Dial. 9, 59-63
130. Kong, P. et al. (2013) Placenta mesenchymal stem cells accelerates wound healing by enhancing angiogenesis in diabetic Goto-Kakizaki (GK) rats. Biochem. Biophys. Res. Commun. 438, 410-419
131. Chotinantakul, K. et al. (2013) Enhancement of wound closure in diabetic mice by ex vivo expanded cord blood CD34+ cells. Cell. Mol. Biol. Lett. 18, 263-283
132. Tark, K. C. et al. (2010) Effects of human cord blood mesenchymal stem cells on cutaneous wound healing in leprdb mice. Ann. Plast. Surg. 65, 565-572
133. Elsharawy, M. A. et al. (2012) Human CD34+ stem cells promote healing of diabetic foot ulcers in rats. Interact. Cardiovasc. Thorac. Surg. 14, 288-293
134. Invernici, G. et al. (2007) Human fetal aorta contains vascular progenitor cells capableofinducing vasculogenesis, angiogenesis, and myogenesisinvitro and ina murine model of peripheral ischemia. Am. J. Pathol. 170, 1879-1892
135. Invernici, G. et al. (2008) Human fetal aorta-derived vascular progenitor cells: identification and potential application in ischemic diseases. Cytotechnology 58, 43-47
136. Barcelos, L. S. et al. (2009) Human CD133+ progenitor cells promote the healing of diabetic ischemic ulcers by paracrine stimulation of angiogenesis and activation of Wnt signaling. Circ. Res. 104, 1095-1102
137. Nie, C. et al. (2011) Locally administered adipose-derived stem cells accelerate wound healing through differentiation and vasculogenesis. Cell Transplant. 20, 205-216
138. Kim, E. K. et al. (2011) The effect of human adipose-derived stem cells on healing of ischemic wounds in a diabetic nude mouse model. Plast. Reconstr. Surg. 128, 387-394
139. Lee, H. C. et al. (2012) Safety and effect of adipose tissue-derived stem cell implantation in patients with critical limb ischemia: a pilot study. Circ. J. 76, 1750-1760
140. Maharlooei, M. K. et al. (2011) Adipose tissue derived mesenchymal stem cell (AD-MSC) promotes skin wound healing in diabetic rats. Diabetes Res. Clin. Pract. 93, 228-234
141. Di Rocco, G. et al. (2010) Enhanced healing of diabetic wounds by topical administration of adipose tissue-derived stromal cells overexpressing stromalderived factor 1: biodistribution and engraftment analysis by bioluminescent imaging. Stem Cells Int http://dx.doi.org/10.4061/2011/304562
142. Hu, P. et al. (2013) CNS inflammation and bone marrow neuropathy in type 1 diabetes. Am. J. Pathol. 183, 1608-1620
143. Dominguez, J. M. I. I. et al. (2014) Combination therapies prevent the neuropathic, pro-inflammatory characteristics of the bone marrow in streptozotocin-induced diabetic rats. Diabetes http://dx.doi.org/10.2337/db14-0433
144. Suva, M. L. (2013) Epigenetic reprogramming in cancer. Science 339, 1567-1570
145. Hou, P. et al. (2013) Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science 341, 651-654